The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180: 5157-5162.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romani, L.
Right arrow Articles by Puccetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romani, L.
Right arrow Articles by Puccetti, P.

IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi1

Luigina Romani2, Teresa Zelante, Antonella De Luca, Francesca Fallarino and Paolo Puccetti2

Department of Experimental Medicine, University of Perugia, Perugia, Italy

Largely viewed as proinflammatory, innate responses combine with adaptive immunity to generate the most effective form of antifungal resistance, and T cells exercise feedback control over diverse effects of inflammation on infection. Some degree of inflammation is required for protection, particularly in mucosal tissues, during the transitional response occurring between the rapid innate and slower adaptive response. However, progressive inflammation worsens disease and ultimately prevents pathogen eradication. IDO, tryptophan catabolites ("kynurenines"), and regulatory T cells help to tame overzealous and exaggerated inflammatory responses. In this context, IL-23 and the Th17 pathway, which down-regulate tryptophan catabolism, may instead favor pathology and serve to accommodate the seemingly paradoxical association of chronic inflammation with fungal persistence. Recent data support a view in which IL-23/IL-17 antagonistic strategies, including the administration of synthetic kynurenines, could represent a new means of harnessing progressive or potentially harmful inflammation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 The original studies conducted in our laboratory were supported by the European Commission’s Specific Targeted Research Projects "EURAPS" (ILSHM-CT-2005) (to L.R.) and "MANASP" (LSHE-CT-2006) (to L.R.) and by funding from the Juvenile Diabetes Research Foundation (to P.P.).

2 Address correspondence and reprint requests to Dr. Luigina Romani and Dr. Paolo Puccetti, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06126 Perugia, Italy. E-mail addresses: lromani{at}unipg.it and plopcc{at}tin.it

3 Abbreviations used in this paper: Treg, regulatory T cell; CGD, chronic granulomatous disease; CMC, chronic mucocutaneous candidiasis; DC, dendritic cell; IRS, immune reconstitution syndrome; PMN, polymorphonuclear neutrophil; ROR, retinoic acid receptor-related orphan receptor.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. Guerrero and B. C. Fries
Phenotypic Switching in Cryptococcus neoformans Contributes to Virulence by Changing the Immunological Host Response
Infect. Immun., September 1, 2008; 76(9): 4322 - 4331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.